Utah Code 26B-4-513. Coprescription guidelines

26B-4-513. Coprescription guidelines.

(1)

As used in this section:

Terms Used In Utah Code 26B-4-513

Controlled substance: means the same as that term is defined in Title 58, Chapter 37, Utah Controlled Substances Act. See Utah Code 26B-4-501
Division: means the Division of Professional Licensing created in Section 58-1-103. See Utah Code 26B-4-501
Opiate: means the same as that term is defined in Section 58-37-2. See Utah Code 26B-4-501
Opiate antagonist: means naloxone hydrochloride or any similarly acting drug that is not a controlled substance and that is approved by the federal Food and Drug Administration for the diagnosis or treatment of an opiate-related drug overdose. See Utah Code 26B-4-501
Physician: means the same as that term is defined in Section 58-67-102. See Utah Code 26B-4-501

(a)	“Controlled substance prescriber” means the same as that term is defined in Section 58-37-6.5.

(b)	“Coprescribe” means to issue a prescription for an opiate antagonist with a prescription for an opiate.

(2)

The department shall, in consultation with the Physicians Licensing Board created in Section 58-67-201, the Osteopathic Physician and Surgeon’s Licensing Board created in Section 58-68-201, and the Division of Professional Licensing created in Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.

Renumbered and Amended by Chapter 307, 2023 General Session

Previous section

Next section

Part 5 Contents